Dr. Barilero is the Chief Regulatory Science Officer, responsible for overseeing all aspects of the Company’s regulatory strategy & operations.
Dr. Barilero brings three decades of experience as a strategic executive in the healthcare industry, successfully designing innovative and integrated regulatory pathways that gained regulatory approvals for new molecular entities in various areas of unmet medical needs across all phases of development in the U.S., EU, Switzerland, China, Japan and Brazil.
Dr. Barilero was most recently Senior Advisor to Innouvo, providing strategic regulatory guidance to scientific ventures. Prior to her most recent position, she held senior positions in Regulatory Sciences and Pharmacovigilance at Agenus and Poxel in Boston. Previously, she was Vice President, Global Head Regulatory Science & Policy at Lundbeck A/S where she played a key role in influencing the external medical and regulatory policy environment that enabled the regulatory approval of Selincro for treatment of alcohol dependance, Trintellix for the treatment of major depressive episodes with effect on cognitive dysfunction and contributing to approval of Rexulti and Abilify Maintena in CNS disorders. Earlier in her career, she held various leadership roles of increasing responsibility in Pharmacology, Clinical Science, Pharmacovigilance, Labeling, Medical Information and Regulatory Affairs & Policy Engagement at Johnson & Johnson, Roche, Wyeth and Bristol Myers Squibb. She started her career as a Researcher at Gustave Roussy in France, the leading European Cancer Center.
Dr. Barilero is an instructor in the Tufts Center for Study of Drug Development course in clinical pharmacology, drug development and regulation. She received her Doctor of Pharmacy & Pharmaceutical Chemistry from the University of Damascus, Syria and her Master of Science and Doctor of Philosophy degrees in Molecular & Cellular Pharmacology, Oncology from the University of Paris VI, France. She also received a Certificate in International Business Communication from San Diego State University and a Certificate in Leadership Transition from the INSEAD business school in Paris, France.